K. Possinger

5.0k citations
156 papers · 3.8k · 1 hit paper · h-index 31

Impact in

  • Oncology top 1%
    • Cancer Treatment and Pharmacology
    • HER2/EGFR in Cancer Research
    • Colorectal Cancer Treatments and Studies
    • Pancreatic and Hepatic Oncology Research
    • Breast Cancer Treatment Studies

Papers in

    • Cancer Treatment and Pharmacology 46
    • HER2/EGFR in Cancer Research 25
    • Colorectal Cancer Treatments and Studies 13
    • Breast Cancer Treatment Studies 29

K. Possinger

146 papers receiving 3.7k citations

K. Possinger's Hit Papers

Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. 1996 · 508 citations
5080+10+20Years since publication100200300400500

Peers

K. Possinger
Comparison fields: 5 of 142
  • Oncology 1.9k
  • Cancer Research 798
  • Biomaterials 390
  • Hematology 289
  • Genetics 231
Replace S.B. Kaye with:
S.B. Kaye United Kingdom
William P. Petros United States
Christian Dittrich Austria
Sewa S. Legha United States
Stephan Bodis Switzerland
Claire F. Verschraegen United States
Donald W. Northfelt United States
Guido Bocci Italy
Mathew L. Thakur United States
Agop Y. Bedikian United States
K. Possinger relative to S.B. Kaye United Kingdom S.B. Kaye's profile →
Citations per field
00.5×
S.B. Kaye · 1×
Citations per year

Countries citing papers authored by K. Possinger

Since Specialization
Citations

This map shows the geographic impact of K. Possinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Possinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Possinger more than expected).

Fields of papers citing papers by K. Possinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Possinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Possinger. The network helps show where K. Possinger may publish in the future.

Co-authors

The 25 scholars most cited alongside K. Possinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with K. Possinger Line = papers co-authored together K. Possinger links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 156 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors.
Hit paper breakdown →
1996508
2 1995302
3 1998181
4 2000146
5 2001143
6 2003142
7 2000118
8 1999107
9 200274
10
Tumor type M2 pyruvate kinase expression in advanced breast cancer.
200173
11 199069
12 200165
13 200365
14 200061
15 200460
16 200456
17 201255
18 200252
19 200051
20 201248

About K. Possinger

K. Possinger is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 156 papers that have together received 3.8k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (46 papers), Breast Cancer Treatment Studies (29 papers), HER2/EGFR in Cancer Research (25 papers), Advanced Breast Cancer Therapies (21 papers), Estrogen and related hormone effects (13 papers), Colorectal Cancer Treatments and Studies (13 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Multiple Myeloma Research and Treatments (8 papers). The work is most often cited by research in Oncology (1.9k citations), Cancer Research (798 citations), Biomaterials (390 citations), Hematology (289 citations) and Genetics (231 citations). K. Possinger has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Orhan Sezer, Jan Eucker, Diana Lüftner, Martin Fenner, Peter Schmid, Maria K. Beykirch, Jackie Walling, Helen Kerr, J Carmichael and Adrian L. Harris. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology, Annals of Hematology and Breast Cancer Research and Treatment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact